Company Overview
Snapshot
Founded in May 2024 by Gil Horsky, Shay Hilel, Prof. Maayan, and Zohar Barbash, Lembas operates with 1–10 employees. The company has secured funding across one round from four investors, with FLORA Ventures identified as a lead investor. In June 2025, Lembas emerged from stealth, announcing its breakthrough discovery in natural GLP-1 for weight management.
Business overview
Lembas develops natural, clinically validated bioactive ingredients for functional foods and supplements, leveraging an AI-powered discovery platform. Its core product, GLP-1 Edge™, is a food-grade peptide designed to enhance the body’s GLP-1 response, supporting appetite regulation and metabolic health. The company serves the functional food and supplement markets, operating within the Agriculture & Food Technologies, Food Tech, and Novel Food & Ingredients sectors, utilizing Artificial Intelligence in its computational biology approach.
Strategic signal
In June 2025, Lembas emerged from stealth, unveiling its GLP-1 Edge™ food additive, a significant development for the weight management and functional food industries. This announcement signals Lembas's readiness to commercialize its AI-driven peptide discovery, offering a non-pharmaceutical approach to metabolic health and appetite regulation. For investors, this indicates a strategic move from R&D to market entry, validating the potential of its proprietary technology and positioning the company as an innovator in precision nutrition.
Log in to access full profile ›Company Intelligence Q&A
- When was Lembas founded?
- Lembas was founded in May 2024.
- Who are the founders of Lembas?
- Lembas was founded by Gil Horsky, Shay Hilel, and Prof. Maayan.
- What is Lembas's primary product?
- Lembas's lead product is GLP-1 Edge™, a food-grade peptide designed to enhance the body’s GLP-1 response for appetite regulation and metabolic health.
- When did Lembas emerge from stealth mode?
- Lembas emerged from stealth in June 2025, announcing its breakthrough discovery in natural GLP-1 for weight management.
- Which investors participated in Lembas's funding round?
- In June 2025, Lembas received funding from FLORA Ventures and Fresh Fund.